News archive
![]() |
LIVERHOPE 3rd Annual Meeting
|
||
![]() |
Position paper of the LIVERHOPE Consortium just published on Journal of Hepatology |
||
![]() |
The LIVERHOPE Nursing paper is now available in Hepatology journal |
||
![]() |
New videos available |
||
![]() |
LIVERHOPE 3rd Annual Meeting 20 March, 2020 Due to the coronavirus emergence, the meeting planned for 20 March 2020 has been cancelled. |
||
![]() |
LIVERHOPE 2nd Annual Meeting 3 June, 2019 |
||
![]() |
Consensus Meeting about Clinical Trials in decompensated Cirrhosis 4 - 5 June, 2019 |
||
![]() |
22 patients June 2019 - 22 patients enrolled in the EFFICACY study |
||
![]() |
First patient included January 2019 - the first patient included in the Efficacy Study in Hospital Clínic, Barcelona, Spain |
||
![]() |
27th Ed. International Congress “Trends and perspectives in hepatology" 30 November - 1 December 2018 At the international conference "Trends and Perspectives in Hepatology 2018" in Padova, Italy, Pere Ginès presented the LIVERHOPE project in the session "Targeting key pathogenic events in order to prevent cirrhosis progression" |
||
![]() |
LIVERHOPE first Annual Meeting June 15, 2018 - Barcelona (TBA) |
||
![]() |
EASL Clinical Practice Guidelines April 2018 - Announcement that 6 investigators from the LiverHope Consortium have participated in the committee that has prepared the EASL Clinical Practice Guidelines for management of patients with decompensated cirrhosis recently presented at the ILC 2018 in Paris and published in Journal of Hepatology |
||
![]() |
EASL ILC April 2018 - The P.Is of the clinical centres met at the recent EASL ILC meeting in Paris to discuss the Efficacy trial |
||
![]() |
Datebase of the safety April 2018 - The database of the safety trial has been closed |
||
![]() |
EASL ILC 2018 April 2018 - At EASL ILC 2018, Pere Ginès presented the LIVERHOPE in a EU Grant application session, the title of his talk was "How I did it" |
||
![]() |
45 patients January 2018 - The recruitment period for the LIVERHOPE SAFETY study has been completed - 45 patients are currently eligible for analysis |
||
![]() |
40 patients November 2017 - 40 patients (89%) validated for the Safety Study and are currently eligible for analysis |
||
![]() |
First two patients August 2017 - the first two patients were enrolled in the Safety Study in the Hospital Clínic |
||
![]() |
LIVERHOPE June 2017 - website online |